Srinivas K. Chunduru

Author

TetraLogic Pharmaceuticals (United States)

Also Known As

S Chunduru, S. Chunduru, S.K. Chunduru, Srinivas Chunduru, Srinivas K Chunduru, Srinivas K. Chunduru, Srinivas K. Chunduru

100

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

TetraLogic Pharmaceuticals (United States)La Trobe University University of Pennsylvania The University of Texas MD Anderson Cancer Center St. Jude Children's Research Hospital

About

Srinivas K. Chunduru is an author at TetraLogic Pharmaceuticals (United States) specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	2.2K
2	Biochemistry	8	8	288
3	Natural Sciences	6	6	266
4	Biomolecular Engineering	3	3	209
5	Engineering	1	1	85

Srinivas K. Chunduru

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis James E. Vince, W. Wei‐Lynn Wong, Nufail Khan, Cell Signal TransductionSignaling PathwayMedicineApoptosisImmunology	2007	1.1K
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα James E. Vince, Diep Chau, Bernard A. Callus, The Journal of Cell Biology	2008	235
In vivo model of adeno-associated virus vector persistence and rescue Sandra Afione, C. Conrad, W.G. Kearns, Journal of Virology In Vivo Gene TherapyImmunologyViral PathogenesisViral DynamicViral Persistence	1996	224
Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models Christopher A. Benetatos, Yasuhiro Mitsuuchi, Jennifer M. Burns, Molecular Cancer Therapeutics Chemoprevention StrategyApoptosisImmunologyCell DeathTumor Biology	2014	173
Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization Rebecca Feltham, Bodhi Bettjeman, Rhesa Budhidarmo, Journal of Biological Chemistry	2011	159
Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies Stephen M. Condon, Yasuhiro Mitsuuchi, Yijun Deng, Journal of Medicinal Chemistry Surgical OncologySolid TumorsApoptosisImmunologyCell Death	2014	149
Methotrexate-resistant Variants of Human Dihydrofolate Reductase with Substitutions of Leucine 22 William S. Lewis, Vivian Cody, Nikolai Galitsky, Journal of Biological Chemistry	1995	145
Mechanism of action of a pestivirus antiviral compound Scott G. Baginski, Daniel C. Pevear, Marty Seipel, Proceedings of the National Academy of Sciences Viral ReplicationMolecular VirologyAntiviral AgentsViral Polymerase StructureMedicine	2000	105
Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796 Anita Y. M. Howe, Huiming Cheng, S V Johann, Antimicrobial Agents and Chemotherapy Viral ReplicationViral Polymerase StructureHepatitis C VirusMolecular BiologyAntiviral Drug	2008	105
The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells Clemens Krepler, Srinivas K. Chunduru, Molly B. Halloran, Clinical Cancer Research	2013	101

Page 1